Overview Varenzin™-CA1 (molidustat oral suspension) is indicated for the control of nonregenerative anemia associated with chronic kidney disease (CKD) in cats.

  • Liquid given orally to the cat once daily for up to 28 days; treatment may be repeated as needed after a minimum seven-day pause
  • Approved for at-home treatment, no in-clinic injections needed
  • For cats 3.4 lb and over
  • Shelf life of 2 years